141 related articles for article (PubMed ID: 30928383)
1. The TLK1-Nek1 axis promotes prostate cancer progression.
Singh V; Jaiswal PK; Ghosh I; Koul HK; Yu X; De Benedetti A
Cancer Lett; 2019 Jul; 453():131-141. PubMed ID: 30928383
[TBL] [Abstract][Full Text] [Related]
2. Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors.
Singh V; Jaiswal PK; Ghosh I; Koul HK; Yu X; De Benedetti A
Int J Cancer; 2019 Aug; 145(4):1055-1067. PubMed ID: 30737777
[TBL] [Abstract][Full Text] [Related]
3. The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1.
Singh V; Khalil MI; De Benedetti A
Cell Cycle; 2020 Feb; 19(3):363-375. PubMed ID: 31914854
[TBL] [Abstract][Full Text] [Related]
4. NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output.
Khalil MI; Ghosh I; Singh V; Chen J; Zhu H; De Benedetti A
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297404
[TBL] [Abstract][Full Text] [Related]
5. Identification of the proteome complement of humanTLK1 reveals it binds and phosphorylates NEK1 regulating its activity.
Singh V; Connelly ZM; Shen X; De Benedetti A
Cell Cycle; 2017 May; 16(10):915-926. PubMed ID: 28426283
[TBL] [Abstract][Full Text] [Related]
6. Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance.
Khalil MI; De Benedetti A
Cancer Drug Resist; 2022; 5(1):93-101. PubMed ID: 35582542
[TBL] [Abstract][Full Text] [Related]
7. Targeting Prostate Cancer, the 'Tousled Way'.
Bhoir S; De Benedetti A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446279
[TBL] [Abstract][Full Text] [Related]
8. NEK1-Mediated Phosphorylation of YAP1 Is Key to Prostate Cancer Progression.
Ghosh I; Khalil MI; Mirza R; King J; Olatunde D; De Benedetti A
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979713
[TBL] [Abstract][Full Text] [Related]
9. TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies.
Khalil MI; Singh V; King J; De Benedetti A
Mol Oncol; 2022 Jul; 16(13):2537-2557. PubMed ID: 35064619
[TBL] [Abstract][Full Text] [Related]
10. Never-in-mitosis related kinase 1 functions in DNA damage response and checkpoint control.
Chen Y; Chen PL; Chen CF; Jiang X; Riley DJ
Cell Cycle; 2008 Oct; 7(20):3194-201. PubMed ID: 18843199
[TBL] [Abstract][Full Text] [Related]
11. Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest.
Pelegrini AL; Moura DJ; Brenner BL; Ledur PF; Maques GP; Henriques JA; Saffi J; Lenz G
Mutagenesis; 2010 Sep; 25(5):447-54. PubMed ID: 20501547
[TBL] [Abstract][Full Text] [Related]
12. Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy.
Singh V; Bhoir S; Chikhale RV; Hussain J; Dwyer D; Bryce RA; Kirubakaran S; De Benedetti A
iScience; 2020 Sep; 23(9):101474. PubMed ID: 32905878
[TBL] [Abstract][Full Text] [Related]
13. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
[TBL] [Abstract][Full Text] [Related]
15. NIMA-related protein kinase 1 is involved early in the ionizing radiation-induced DNA damage response.
Polci R; Peng A; Chen PL; Riley DJ; Chen Y
Cancer Res; 2004 Dec; 64(24):8800-3. PubMed ID: 15604234
[TBL] [Abstract][Full Text] [Related]
16. Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1.
Freund I; Hehlgans S; Martin D; Ensminger M; Fokas E; Rödel C; Löbrich M; Rödel F
Cells; 2020 May; 9(5):. PubMed ID: 32429458
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.
Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M
Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914
[TBL] [Abstract][Full Text] [Related]
18. Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression.
Khalil MI; Madere C; Ghosh I; Adam RM; De Benedetti A
Pathophysiology; 2021 Jul; 28(3):339-354. PubMed ID: 35366279
[TBL] [Abstract][Full Text] [Related]
19. Mutation of NIMA-related kinase 1 (NEK1) leads to chromosome instability.
Chen Y; Chen CF; Chiang HC; Pena M; Polci R; Wei RL; Edwards RA; Hansel DE; Chen PL; Riley DJ
Mol Cancer; 2011 Jan; 10(1):5. PubMed ID: 21214959
[TBL] [Abstract][Full Text] [Related]
20. Increased Nek1 expression in renal cell carcinoma cells is associated with decreased sensitivity to DNA-damaging treatment.
Chen Y; Chen CF; Polci R; Wei R; Riley DJ; Chen PL
Oncotarget; 2014 Jun; 5(12):4283-94. PubMed ID: 24970796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
